HSLVX | WCMNX | HSLVX / WCMNX | |
Total Expense Ratio | 0.87 | 1.24 | 70% |
Annual Report Gross Expense Ratio | 0.87 | 2.04 | 43% |
Fund Existence | 11 years | 6 years | - |
Gain YTD | 0.124 | 5.043 | 2% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 1000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 295M | 45.1M | 654% |
Annual Yield % from dividends | 1.34 | 0.00 | - |
Returns for 1 year | -8.98 | 3.09 | -290% |
Returns for 3 years | 11.64 | 22.63 | 51% |
Returns for 5 years | -14.75 | 14.91 | -99% |
Returns for 10 years | -4.26 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
RYOAX | 55.49 | -0.04 | -0.07% |
Rydex Biotechnology H | |||
RGCIX | 10.17 | -0.04 | -0.39% |
Russell Inv Global Infrastructure C | |||
TCIEX | 27.08 | -0.21 | -0.77% |
Nuveen International Eq Idx R6 | |||
GIRNX | 31.88 | -0.31 | -0.96% |
Goldman Sachs International Eq ESG Inv | |||
PGSGX | 18.01 | -0.23 | -1.26% |
JPMorgan Small Cap Growth A |